TY - JOUR
T1 - The COVID-19 pandemic
T2 - a rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI and St Jude Global
AU - Sullivan, Michael
AU - Bouffet, Eric
AU - Rodriguez-Galindo, Carlos
AU - Luna-Fineman, Sandra
AU - Saghir Khan, Muhammad
AU - Kearns, Pamela
AU - Hawkins, Douglas S.
AU - Challinor, Julia
AU - Morrissey, Lisa
AU - Fuchs, Jörg
AU - Marcus, Karen
AU - Balduzzi, Adriana
AU - Basset-Salom, Luisa
AU - Caniza, Miguela
AU - Baker, Justin N.
AU - Kebudi, Rejin
AU - Hessissen, Laila
AU - Sullivan, Richard
AU - Jones, Kathy-Pritchard
PY - 2020/5/13
Y1 - 2020/5/13
N2 - The COVID-19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades. This Special Report aims to summarise general principles for continuing multi-disciplinary care during the SARS-CoV-2 (COVID-19) pandemic. With contributions from the leadership of the International Society for Paediatric Oncology (SIOP), Children’s Oncology Group (COG), St Jude Global programme and Childhood Cancer International, we have sought to provide a framework for healthcare teams caring for children with cancer during the pandemic. We anticipate the burden will fall particularly heavily on children, their families and cancer services in low- and middleincome countries. Therefore, we have brought together the relevant clinical leads from SIOPEurope, COG and SIOP-PODC (Pediatric Oncology in Developing Countries) to focus on the six most curable cancers that are part of the WHO Global Initiative in Childhood Cancer. We provide some practical advice for adapting diagnostic and treatment protocols for children with cancer during the pandemic, the measures taken to contain it (e.g. extreme social distancing) and how to prepare for the anticipated recovery period.
AB - The COVID-19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades. This Special Report aims to summarise general principles for continuing multi-disciplinary care during the SARS-CoV-2 (COVID-19) pandemic. With contributions from the leadership of the International Society for Paediatric Oncology (SIOP), Children’s Oncology Group (COG), St Jude Global programme and Childhood Cancer International, we have sought to provide a framework for healthcare teams caring for children with cancer during the pandemic. We anticipate the burden will fall particularly heavily on children, their families and cancer services in low- and middleincome countries. Therefore, we have brought together the relevant clinical leads from SIOPEurope, COG and SIOP-PODC (Pediatric Oncology in Developing Countries) to focus on the six most curable cancers that are part of the WHO Global Initiative in Childhood Cancer. We provide some practical advice for adapting diagnostic and treatment protocols for children with cancer during the pandemic, the measures taken to contain it (e.g. extreme social distancing) and how to prepare for the anticipated recovery period.
KW - Burkitt lymphoma
KW - COVID-19
KW - Hodgkin lymphoma
KW - Nephroblastoma
KW - Retinoblastoma
KW - SARS-CoV2
KW - WHO Global Initiative on Childhood Cancer
KW - Wilms tumour
KW - acute lymphoblastic leukaemia
KW - childhood cancer
KW - low grade glioma
KW - paediatrics
UR - https://siop-online.org/news/the-covid-19-pandemic-a-rapid-global-response-for-children-with-cancer-from-siop-cog-siop-e-siop-podc-ipso-pros-cci-and-st-jude-global/
U2 - 10.1002/pbc.28409
DO - 10.1002/pbc.28409
M3 - Article
SN - 1545-5009
VL - 67
JO - Pediatric Blood & Cancer
JF - Pediatric Blood & Cancer
IS - 7
M1 - e28409
ER -